Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Exelixis Inc (NASDAQ:EXEL)

23.11
Delayed Data
As of 4:00pm ET
 -0.01 / -0.04%
Today’s Change
3.55
Today|||52-Week Range
23.49
+55.00%
Year-to-Date
Intercept (ICPT) to Post Q4 Earnings: What's in the Cards?
7:15pm / Zacks.com - Paid Partner Content
Merrimack (MACK): What Awaits the Stock in Q4 Earnings?
Feb 17 / Zacks.com - Paid Partner Content
Ionis (IONS) Q4 Earnings: What's in the Cards for the Stock?
7:15pm / Zacks.com - Paid Partner Content
Radius Health (RDUS) Q4 Earnings: Will the Stock Disappoint?
Feb 17 / Zacks.com - Paid Partner Content
Patterson Companies (PDCO) Q3 Earnings: What's in Store?
9:27am / Zacks.com - Paid Partner Content
BioMarin (BMRN) Q4 Earnings: Will it Post a Beat Again?
Feb 17 / Zacks.com - Paid Partner Content
Forget Alexion, Buy these 4 Biotech Stocks Instead
Feb 20 / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Gilead Sciences, Celgene, Fate Therapeutics, Exeli...
Feb 14 / Zacks.com - Paid Partner Content
Medtronic (MDT) Q3 Earnings: Disappointment in the Cards?
Feb 20 / Zacks.com - Paid Partner Content
Better Buy: Exelixis, Inc. vs. Bristol-Myers Squibb
Feb 13 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close23.12
Today’s open22.60
Day’s range22.94 - 23.49
Volume3,934,172
Average volume (3 months)5,796,120
Market cap$6.6B
Dividend yield--
Data as of 4:00pm ET, 02/21/2017

Growth & Valuation

Earnings growth (last year)+41.30%
Earnings growth (this year)+47.90%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+48.03%
P/E ratioNM
Price/Sales31.75
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ICLRICON PLC-0.85-0.99%
CRLCharles River Labora...-0.10-0.11%
PRAHPRA Health Sciences ...-0.63-1.03%
PRXLPAREXEL Internationa...-0.39-0.59%
Data as of 4:02pm ET, 02/21/2017

Financials

Next reporting dateFebruary 28, 2017
EPS forecast (this quarter)-$0.01
Annual revenue (last year)$37.2M
Annual profit (last year)-$169.7M
Net profit margin-456.63%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael M. Morrissey
Chief Financial Officer &
Executive Vice President
Christopher J. Senner
Corporate headquarters
South San Francisco, California

Forecasts


Search for Jobs